Tivicay
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Dolutegravir
- Made by
- ViiV Healthcare BV
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. Tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
Details
| Made by | ViiV Healthcare BV |
|---|---|
| Active substance | Dolutegravir |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AX12 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2014-01-16 |
| Last updated by the regulator | 2025-11-14 |
| EMA product number | EMEA/H/C/002753 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).